Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | PLAU | P00749 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6652156 | 0.81 | ALDH1A1 (0.34) | KDM4EHPGDALDH1A1HSD17B10MEN1 | |
| SCHEMBL6069155 | 0.70 | CYP3A4 (0.48) | TAAR1CA2ALDH1A1CYP3A4TSHR | |
| SCHEMBL30937686 | 0.70 | ALDH1A1 (0.36) | TAAR1ALDH1A1 | |
| SCHEMBL24620497 | 0.69 | NOS3 (0.35) | KDM4EHPGDALDH1A1HSD17B10MEN1 | |
| SCHEMBL7203265 | 0.69 | NPC1 (0.46) | TAAR1LMNASMN1; SMN2ALDH1A1HSD17B10 | |
| SCHEMBL5550176 | 0.69 | ALDH1A1 (0.50) | TAAR1LMNASMN1; SMN2CA2ALDH1A1 | |
| SCHEMBL16613034 | 0.69 | ALDH1A1 (0.34) | ALDH1A1 | |
| Methylamine SCHEMBL27540106 | 0.68 | TAAR1 (0.63) | TAAR1LMNASMN1; SMN2CA2ALDH1A1 | |
| SCHEMBL3869091 | 0.68 | LMNA (0.43) | TAAR1LMNAKDM4EHPGDALDH1A1 | |
| SCHEMBL169957 | 0.67 | F2RL1 (0.33) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1654269-B1 | NOVEL COMPOUNDS | MITSUBISHI TANABE PHARMA CORP (JP) | 2014-10-15 | — | — | EP | disclosed |
| US-7521430-B2 | N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| US-20070060545-A1 | Novel compounds | TANABE SEIYAKU CO., LTD. (JP) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060545-A1 | Novel compounds | CYP1B1, CYP2B6, CYP4B1 | TAAR1 1849/4885LMNA 1830/4885SMN1; SMN2 4048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.